News        Sectors        Watchlists

Navidea Biopharmaceuticals Inc. (NAVB)

NAVB stock forecast: buy or sell

Close on Sep 25th, 2020
$2.73 -0.01%
3 months performance
Published: September 26th, 2020 - 07:05

NAVB stock outlook

  • Navidea Biopharmaceuticals closed yesterday at $2.73 (-1.09%) prior to reporting earnings at
  • Looking at the chart, price is drawing an scaled downtrend since mid-July with lower tops and lower bottoms. this downtrend marked a -49.07% loss(from its highs at $5.36).
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.

The opinions published in this article are personal and not recommendations for you to buy or sell stocks. The author of this text does not know the particular positions of the reader, his or her own finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are posted for educative purposes only

NAVB stock charts

Should I buy Navidea Biopharmaceuticals stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is NAVB stock a buy?

In the current situation of Navidea Biopharmaceuticals there is not any eligible buy setup. This doesn't mean we expect a selloff for NAVB in the next few days, or that it may not climb higher. Simply, it doesn't match our recommended trading systems

Should I sell Navidea Biopharmaceuticals stock?

When is it time to sell Navidea Biopharmaceuticals stock?. Much like when we have to buy shares, determining when is appropiate to sell is not a haphazard decision, and we must follow our own trading style. When selling, as well as buying, detailed strategies are very easy to follow but are only valid for selling shares in your porfolio, not for selling short Navidea Biopharmaceuticals stock

A guiding principle is that you should never hold a trade that results in higher than expected losses by the time of the buy. When to sell your stock should always be determined by the stop-loss (automatic or manual)

Is it time to sell Navidea Biopharmaceuticals stock?

Currently, Navidea Biopharmaceuticals stock doesn't match any of our preferred sell setups, so if you hold Navidea Biopharmaceuticals shares and your operation is in profit probably is not time to sell now

Analysts' recommendations to buy or sell Navidea Biopharmaceuticals stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

In the last 30 days we couldn't find any rating for Navidea Biopharmaceuticals

Technical analysis

From a technical standpoint, Navidea Biopharmaceuticals continues in downtrend since mid-July, and has droppped a -49.07%. The stock plotted 2 consecutive lower tops

SMAs overview

A favorite tool of many trading systems are the moving averages, that easily show trend momentum. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days

NAVB SMAs chart

Supports and resistances

Traders use supports and resistances as a way to spot price points in the stock price action that tend to work as obstacles, preventing the price of a stock to move up or down. A support level is a level where the price may find support as it falls. Price is more likely to "rebound" this level rather than break through it. However, if the price breaks down the support, it is likely to continue declining until approaching another support level. On the other hand, a resistance level is where the price may find a curb as it moves up. Likewise, the price is more liable to "rebound" at this level, and if it finally breaks this level, it will rally easily until it finds the next resistance

The current resistance levels are:

  • R1: $3.05 (11.72% above)
  • R2: $3.20 (17.22% above)
  • R3: $3.60 (31.87% above)
  • The current support levels are:

  • S1: $2.60 (-4.76% below)
  • S2: $2.55 (-6.59% below)
  • S3: $2.40 (-12.09% below)
  • Bollinger bands

    This is an indicator that was created in the 1980s by John Bollinger. It comprises three lines that are outlined superimposed on the price evolution chart:

    • The central band is a moving average, usually a simple moving average calculated with 20 periods
    • The upper band is calculated by adding to the value of the simple moving average 2 times the standard deviation of the moving average
    • The lower band is calculated by subtracting from the simple moving average 2 times the standard deviation of the moving average

    The price is moving near to the lower Bollinger band, indicating some level of oversold in recent sessions. This is not a bullish indicator, as price can trade in these levels for many days and weeks

    NAVB RSI chart

    Relative strength index

    The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. It is intended to plot the current and past weakness or strength of a stock or market based on the closing prices of a recent trading period. Like other oscillation indicators, the RSI ranges from 0% to 100%. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in 1978

    The RSI broke out the oversold level of 30 in late August after just being in the oversold zone for just one day (what can be considered a strength signal). The RSI reading yesterday was 38.25

    NAVB RSI chart

    Earnings and financials

    NAVB hosted the earnings call and presented the second-quarter report in mid-August. The Wall St estimate is a earnings of %s per-share of $-0.12, that is a 0% higher than previous reported quarter. NAVB beat market estimates and posted a per-share earnings of %s of $-0.11, that is a 8.33% improvement versus the forecasts of $-0.12.

    Same quarter one year ago, reported EPS was $-0.24, so recently reported EPS is a gain of 54.17%. Turnover merely moved on an annualized basis in the Q2, from $2,600,920 to $2,711,010 last quarter.

    NAVB is releasing earnings report. Earnings reporting day has an additional risk for traders as the results published can jump up or down the price with lower volume and not respecting your buy or stop-loss orders. You can find more information about the earnings call and the earnings reports on the Investor Relations section of its website:

    NAVB revenues and profits chart